Today: 21 June 2026
Browse Category

Stock Market 9 December 2025

US stock markets reopened on June 21, 2026, after being closed for Juneteenth and the weekend. MercadoLibre rose 2.87% over the last five sessions, with a Galperin-linked trust maintaining its stake after an internal move. Vistra gained 3.1% Thursday and 10.6% for the week, driven by investor focus on AI data center power demand, and its stock goes ex-dividend soon. Home Depot was up 2.1% Thursday, but new housing data weighed on the home-improvement outlook. Bank of America experienced significant app and online banking disruptions, with over 5,000 user complaints reported. General Motors closed at $79.29, down 0.36% Thursday and 2.7% for the week, erasing earlier gains. Joby Aviation rose 6.5% Thursday and 9.3% for the week, with investors watching FAA certification and cash use. Constellation Energy climbed 8% for the week, with attention on whether new grid rules and project approvals will convert AI power demand into cash flow. Broadcom gained 4.7% Thursday but remains below its June 3 high as investors reassess AI expectations. Cerebras Systems rose 9.85% Thursday and 9.7% for the week, but still trades well below its debut price, with earnings due July 2. GE Aerospace outperformed major indexes, rising 6.7% for the week, ahead of its July 16 earnings. Roblox jumped 7.31% Thursday, with engagement up for a third week, helped by new content and its return to Russia. Dell fell 2.34% Tuesday but is up 3.5% since June 12. Applied Digital rose 2.24% Thursday and 9.1% for the week, after completing a $1.59 billion notes sale. Oklo gained 4% Thursday, with a Centrus Energy fuel agreement in place. Robinhood surged 16% for the week, announcing a 10% workforce reduction and $28 million in restructuring charges. CoreWeave rose 17.3% ahead of joining the Nasdaq-100. Coherent gained 2.8% Thursday, announcing a $50 million CHIPS Act letter of intent. Applied Optoelectronics fell 3.3% Thursday and 4.3% for the week, with filings and management comments under scrutiny. Micron jumped 8.7% Thursday and 15.5% for the week, with upcoming earnings seen as a key test for the AI memory sector.
CrowdStrike Stock (CRWD) on December 9, 2025: Price Action, AI Deals, Analyst Targets and 2026 Outlook

CrowdStrike Stock (CRWD) on December 9, 2025: Price Action, AI Deals, Analyst Targets and 2026 Outlook

CrowdStrike shares traded around $520–521 on December 9, 2025, after Q3 results topped estimates, with revenue up 22% to $1.23 billion and adjusted EPS at $0.96. The company raised full-year guidance, but GAAP net income remained negative at –$19 million. Market cap stands near $130 billion. Wall Street continues to lift price targets despite concerns over the stock’s high valuation.
9 December 2025
····
Walmart (WMT) Stock on December 9, 2025: Nasdaq Debut, Tech Pivot and 2026 Outlook

Walmart (WMT) Stock on December 9, 2025: Nasdaq Debut, Tech Pivot and 2026 Outlook

Walmart began trading on the Nasdaq on December 9, 2025, after leaving the NYSE, with shares at $114–115 and a market cap near $910 billion. The stock trades at about 40 times earnings, well above the sector average, and sits just below its 52-week high. Over five years, Walmart has returned 131%, outpacing the S&P 500 by nearly 30 points. Analysts note the move could draw around $20 billion in new passive investment.
9 December 2025
··
Johnson & Johnson Stock Today: Q3 Beat, Orthopaedics Spin-Off and New Cancer Data Power a 40% Rally

Johnson & Johnson Stock Today: Q3 Beat, Orthopaedics Spin-Off and New Cancer Data Power a 40% Rally

Johnson & Johnson shares closed at $201.62 on December 8, 2025, up nearly 40% year to date and valuing the company at about $486 billion. The stock surged after a Q3 earnings beat, raised full-year guidance, and a surprise plan to spin off its DePuy Synthes orthopaedics unit. JNJ remains a key driver of recent Dow gains. Technical models project up to 16% further upside by March 2026.
9 December 2025
··
Salesforce (CRM) Stock on December 9, 2025: Q3 FY26 Beat, AI Agentforce Momentum and What Comes Next

Salesforce (CRM) Stock on December 9, 2025: Q3 FY26 Beat, AI Agentforce Momentum and What Comes Next

Salesforce shares traded near $260 on December 9, 2025, after reporting record Q3 results and raising its full-year outlook. The company posted Q3 revenue of about $10.3 billion, up 9% year-over-year, and adjusted EPS of $3.25, beating estimates. Market cap stood at roughly $243 billion. The stock remains about 25–30% lower for 2025 despite the recent rebound.
9 December 2025
···
Ascendis Pharma (ASND) Stock Slides After Q3 Miss and FDA Delay – What Investors Need to Know on December 9, 2025

Ascendis Pharma (ASND) Stock Slides After Q3 Miss and FDA Delay – What Investors Need to Know on December 9, 2025

Ascendis Pharma shares fell 4.2% to around $197.25 in late trading December 9 after a Q3 earnings miss and a three-month FDA review delay for its key dwarfism drug. Volume was about 76% below average. The company posted Q3 revenue of €213.6 million but reported a net loss of €61 million, mainly from finance expenses. Despite the pullback, ASND remains near its 52-week high and up year-on-year.
9 December 2025
··
BitMine Immersion Technologies (BMNR) Stock Soars as Ethereum Treasury Hits 3.86 Million ETH – Latest News, Forecasts and Risks (Dec. 9, 2025)

BitMine Immersion Technologies (BMNR) Stock Soars as Ethereum Treasury Hits 3.86 Million ETH – Latest News, Forecasts and Risks (Dec. 9, 2025)

BitMine Immersion Technologies shares jumped 8.4% to $38.85 intraday on December 9, 2025, after confirming control of 3.86 million ETH—over 3.2% of all Ethereum—and a $13.2 billion crypto and cash reserve. The company’s market cap stands at $14.8 billion with a trailing P/E of about 2.7. The stock traded between $34.66 and $39.25 during the session. Volume averaged 45 million shares over 30 days.
9 December 2025
····
KE Holdings (BEKE) Stock Slides as Buybacks Accelerate: What Q3 2025 Earnings and China’s Housing Slump Mean for Investors

KE Holdings (BEKE) Stock Slides as Buybacks Accelerate: What Q3 2025 Earnings and China’s Housing Slump Mean for Investors

KE Holdings (NYSE: BEKE) shares fell about 4.8% Tuesday, opening near $16.35 after closing at $17.08, with over 1 million shares traded. The drop came despite ongoing share buybacks and Q3 revenue rising 2.1% year-on-year to RMB 23.1 billion. Net income fell to RMB 747 million from RMB 1.17 billion a year earlier. BEKE underperformed even as international ETF VXUS saw strong inflows.
9 December 2025
····
Summit Therapeutics (SMMT) Stock on December 9, 2025: Trial Optimism Collides With High Risk, High Volatility

Summit Therapeutics (SMMT) Stock on December 9, 2025: Trial Optimism Collides With High Risk, High Volatility

Summit Therapeutics shares traded at $17–18 on December 9, 2025, near the low end of their 52-week range of $15.55 to $36.91. The company’s lung cancer drug ivonescimab recently outperformed Keytruda in a limited trial, drawing attention but also regulatory questions. Summit granted inducement stock options to new hires on December 5. The company’s market cap stands near $13–14 billion.
9 December 2025
·
Credo Technology Group (CRDO) Stock: Earnings Blowout, AI Tailwinds, and What Comes Next

Credo Technology Group (CRDO) Stock: Earnings Blowout, AI Tailwinds, and What Comes Next

Credo Technology Group shares traded near $169 on December 9, 2025, down from a record $213.80 hit a week earlier after strong earnings. The company reported Q2 fiscal 2026 revenue of $268 million, far above estimates, and net income of $82.6 million versus a loss last year. Management raised Q3 guidance to $335–$345 million in revenue, citing demand from AI data centers.
9 December 2025
···
Olema Pharmaceuticals (OLMA) Stock: Latest News, Forecast & Analysis as of December 9, 2025

Olema Pharmaceuticals (OLMA) Stock: Latest News, Forecast & Analysis as of December 9, 2025

Olema Pharmaceuticals shares traded at $26–27 on December 9, up over 800% from their 52-week low but 12% below the recent high. The stock surged after Roche’s positive Phase 3 results for a similar breast cancer drug, triggering analyst upgrades and price target hikes. Market capitalization now stands near $2–2.2 billion. Analyst 12-month targets range from $20 to $55, with most rating the stock a strong buy.
9 December 2025
··
Ferguson Enterprises (FERG) Stock Slides After Q1 2026 Earnings – What Today’s Sell-Off Means for Investors

Ferguson Enterprises (FERG) Stock Slides After Q1 2026 Earnings – What Today’s Sell-Off Means for Investors

Ferguson Enterprises reported Q1 net sales of $8.17–8.2 billion, up 5.1% year-on-year, and adjusted diluted EPS of $2.84, up 15.9%. Shares fell sharply despite raised full-year guidance, as investors weighed valuations and growth forecasts. Residential revenue slipped 1%, while non-residential revenue jumped 12% on strong commercial demand. The company now targets 5% net sales growth for 2025.
9 December 2025
···
Graphic Packaging (GPK) Stock Hits 52-Week Low as Earnings Guidance Cut and CEO Transition Rattle Investors

Graphic Packaging (GPK) Stock Hits 52-Week Low as Earnings Guidance Cut and CEO Transition Rattle Investors

Graphic Packaging shares fell to a new 52-week low near $14 on December 9, 2025, after the company cut its full-year earnings outlook and announced cost and production optimization measures. Trading volume topped 10 million shares. The company also confirmed a CEO transition for early 2026. Net sales guidance remains at $8.4–$8.6 billion.
9 December 2025
··
Inspire Medical Systems (INSP) Stock on December 9, 2025: Rebound Rally Meets Legal Overhang and Mixed Analyst Targets

Inspire Medical Systems (INSP) Stock on December 9, 2025: Rebound Rally Meets Legal Overhang and Mixed Analyst Targets

Inspire Medical Systems shares traded at $141.72 on December 9, 2025, after a volatile year that included a 21% surge two weeks prior following an analyst upgrade and positive reimbursement news. Q3 revenue rose 10% to $224.5 million, with net income at $9.9 million and adjusted EPS of $0.38, beating estimates. The company also launched its new Inspire 5 system.
9 December 2025
·
Kontoor Brands (KTB) Stock on December 9, 2025: Q3 Beat, Analyst Upgrades and Volatile Trading Create a 2026 Upside Story

Kontoor Brands (KTB) Stock on December 9, 2025: Q3 Beat, Analyst Upgrades and Volatile Trading Create a 2026 Upside Story

Kontoor Brands shares traded between $75 and $76 on December 9, about 19% below their January high, after falling 3–4% intraday amid weak consumer data. Wells Fargo raised its price target to $100 and reiterated an “overweight” rating. Marshall Wace trimmed its stake following recent gains. Kontoor’s Q3 revenue rose 27% to $853 million, with EPS of $1.44 beating forecasts.
9 December 2025
··
1 … 1,220 1,221 1,222 1,223 1,224 … 1,575

Stock Market Today

  • Why Verizon (VZ) Remains an Undervalued Pick on the NYSE
    June 21, 2026, 8:03 AM EDT. Verizon Communications Inc. (NYSE: VZ) has completed tender offers to repurchase ~$1.86 billion in notes, easing its debt load by removing restrictive covenants in bond agreements. This move concludes Verizon's strategic debt management effort, potentially enhancing financial flexibility. Operating as a major U.S. telecom holding company, Verizon provides wireless, wireline, and streaming services to various customer segments. Despite its status as an undervalued NYSE stock, some analysts suggest AI stocks offer higher growth potential with lower risk. Investors seeking value may consider Verizon's stable cash flow and ongoing restructuring as positives compared to more volatile sectors.

Latest articles

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 21.06.2026

21 June 2026
LIVEMarkets rolling coverageStarted: June 21, 2026, 4:00 AM EDTUpdated: June 21, 2026, 8:30 AM EDT Why Verizon (VZ) Remains an Undervalued Pick on the NYSE June 21, 2026, 8:03 AM EDT. Verizon Communications Inc. (NYSE: VZ) has completed tender offers to repurchase ~$1.86 billion in notes, easing its debt load by removing restrictive covenants in bond agreements. This move concludes Verizon’s strategic debt management effort, potentially enhancing financial flexibility. Operating as a major U.S. telecom holding company, Verizon provides wireless, wireline, and streaming services to various customer segments. Despite its status as an undervalued NYSE stock, some analysts suggest AI
Go toTop